RNA Competitors & Alternatives
Compare Atrium Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RNA
Main Stock$11.33
Tradestie Score
54
Market Cap
$6.27B
Revenue Growth
11.5%
Analyst Upside
+120.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$32.84
|
$256.54M | - | 55 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.65
|
$240.89M | - | 55 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$10.80
|
$211.22M | - | 47 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.33
|
$202.58M | - | 60 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.67
|
$199.71M | - | 46 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$24.73
|
$188.81M | 325.8 | 47 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.69
|
$180.53M | - | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.09
|
$170.45M | - | 57 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.25
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$22.21
|
$154.27M | - | 61 | Compare |
More RNA Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry